Get Protein Services Quote

meet the team

ATUM’s team is built of knowledge, expertise, and experience. With a combined experience of over 30 years, Michael Feldhause, SVP of Antibodys, and James Love, Director of protein expression, have built a state-of-the-art expression platform and lead a team of talented scientists.


Michael Feldhaus, Ph.D.

Dr. Feldhaus co-founded MIGS LLC in September of 2013. MIGS has developed the capacity, speed and high throughput, small scale production capabilities to support discovery efforts which may utilize in silico design, deep sequencing of immune repertoires and antibody fragment based discovery platforms. Previously, as the Executive Vice President of Research at Adimab, Dr. Feldhaus led teams that would ultimately develop the premier IgG antibody discovery and optimization platform. Dr. Feldhaus successfully designed and managed more than 25 antibody discovery projects while at Adimab with over 20 pharmaceutical companies. Dr. Feldhaus is on the advisory board for Cambridge Health Tech, and he has more than 20 patents (issued and applications). Dr. Feldhaus completed his undergraduate degree in Microbiology at the University of Illinois in Champaign-Urbana, and holds a Ph.D. in Experimental Pathology from the School of Medicine at the University of Utah.

James_Love_042016

James Love, Ph.D.

Dr. James Love joined ATUM in 2015 as Director of Expression Technologies to spearhead the development of protein services that ATUM now offers, at our new 50,000 sq ft facility in Newark, CA. James was trained as a structural biologist at the MRC-LMB in Cambridge, UK before postdoctoral work at Columbia University. He went on to become the Head of Research at the New York Consortium on Membrane Protein Structures where he developed high-throughput methods for producing integral membrane proteins. He then joined the New York Consortium Structural Genomics Research Consortium where he developed methods for the production of human proteins in mammalian cells. He is an author on 35 publications, including several in Nature, and is an author on over 450 protein structures.